+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Factors of failure in fluconazole therapy of oral and esophageal candidiasis in HIV-infected patients



Factors of failure in fluconazole therapy of oral and esophageal candidiasis in HIV-infected patients



Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 35: 96




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031413940

Download citation: RISBibTeXText


Related references

Clinical failure of fluconazole in prophylaxis of esophageal candidiasis in hiv infected patients. Bulletin de la Societe Francaise de Mycologie Medicale 19(2): 155-158, 1990

Comparison of itraconazole oral solution and fluconazole capsules in the treatment of oral and esophageal candidiasis in hiv infected patients preliminary results. Istituto Superiore Di Sanita Vii International Conference on Aids: Science Challenging Aids; Florence, Italy, June 16-21, 464p (Vol 1); 460p (Vol 2) Istituto Superiore Di Sanita: Rome, Italy Paper : 232, 1991

Fluconazole therapy of oral candidiasis in HIV-infected patients: results of a multicentre study. Infection 22(2): 118-123, 1994

A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance. American Journal of Medicine 105(1): 7-11, 1998

Fluconazole in maintenance therapy of oral candidiasis in hiv infected adults. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Thb 384, 1990

Single dose therapy for oral candidiasis with fluconazole in hiv infected adults. Morisset, R A (Ed ) Ve Conference Internationale Sur Le Sida: Le Defi Scientifique Et Social; V International Conference on Aids: The Scientific And Social Challenge; Montreal, Quebec, Canada, June 4-9, 1262p International Development Research Centre: Ottawa, Ontario, Canada Illus Paper 469, 1989

Treatment of oropharyngeal and esophageal candidiasis with a new antifungal agent fluconazole in hiv infected patients. Current Therapeutic Research 47(1): 81-87, 1990

Amphotericin B oral suspension for fluconazole-resistant oral candidiasis in HIV-infected patients. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 37: 271, 1997

Fluconazole resistant oral candidiasis in HIV-infected patients. Oral Diseases 3(Suppl. 1): S110-S112, 1997

Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients. Journal of ChemoTherapy 4(6): 381-386, 1992

Fluconazole in the treatment of esophageal, bronchial and oral candidiasis in patients with ARC and AIDS. Giornale Italiano di Chemioterapia 35(1-3): 61-68, 1988

Prognostic factors for the clinical effectiveness of fluconazole in the treatment of oral candidiasis in HIV-1-infected individuals. Pharmacological Research 46(1): 89-94, 2002

Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus. Antimicrobial Agents and ChemoTherapy 34(11): 2267-2268, 1990

Relapses of oral candidiasis in HIV infected patients under fluconazole prophylaxis. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS [Author] IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 366, 1993

Single-dose therapy for oral candidiasis with fluconazole in HIV-infected adults: a pilot study. Journal of Infectious Diseases 159(4): 806-807, 1989